help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2007.060642 on November 30, 2007

Published online before print November 30, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2007.060642v1
171/6/1887    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amaral, F. A.
Right arrow Articles by Souza, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amaral, F. A.
Right arrow Articles by Souza, D. G.
(American Journal of Pathology. 2007;171:1887-1893.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060642

The Role of Macrophage Migration Inhibitory Factor in the Cascade of Events Leading to Reperfusion-Induced Inflammatory Injury and Lethality

Flávio A. Amaral*{dagger}, Caio T. Fagundes*{dagger}, Rodrigo Guabiraba*, Angélica T. Vieira*, Adriano L.S. Souza*, Remo C. Russo*, Milena P.B. Soares{ddagger}, Mauro M. Teixeira* and Danielle G. Souza{dagger}

From the Departamentos de Bioquímica e Imunologia* and Microbiologia,{dagger} Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte; and the Instituto Gonçalo Muniz,{ddagger} Fundação Osvaldo Cruz, Salvador, Brazil

Ischemia and reperfusion (I/R) injury is associated with a systemic inflammatory response, characterized by intense tumor necrosis factor (TNF)-{alpha} production and TNF-{alpha}-dependent tissue injury. Macrophage migration inhibitory factor (MIF) is a potent proinflammatory cytokine that may induce TNF-{alpha} release and play an important role in innate immune and inflammatory responses. The aim of this work was to assess whether MIF was involved the inflammatory cascade and injury that follows intestinal I/R. To this end, wild-type (WT) and MIF-deficient (MIF–/–) mice underwent 60 minutes of ischemia followed by 60 minutes of reperfusion, after which they were culled for the assessment of inflammatory parameters. I/R was accompanied by an increase in circulating levels of MIF and an increase of vascular permeability, hemorrhage, and production of TNF-{alpha} in the intestine and lungs. The latter parameters were markedly suppressed in reperfused MIF–/– mice, and this was associated with decreased lethality (80% in WT versus 20% in MIF–/– mice). Interestingly, the reperfusion-associated neutrophil accumulation in the intestine and lungs was similar in WT and MIF–/– mice. Leukocytes isolated from lungs of MIF–/– mice were less activated, as assessed by their response to zymosan in a luminol-enhanced chemiluminescence assay. In conclusion, our results suggest that MIF plays an important role in the cascade of events leading to TNF-{alpha} production and reperfusion-induced tissue injury and lethality in mice.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.